Collagen Dressings Market Outlook:
Collagen Dressings Market size was valued at USD 854.4 million in 2024 and is projected to reach USD 2.3 billion by the end of 2037, rising at a CAGR of 7.7% during the forecast period, i.e., 2025-2037. In 2025, the industry size of collagen dressings is estimated at 914.7 million.
The worldwide patient population necessitating collagen dressings is observed to be substantially high due to the expanding wound cases. This has resulted in the progressive development of the market in almost all nations. As evidence, the World Health Organization article published in 2023 states that over 8 million individuals in the U.S. are affected by chronic wounds, out of which diabetic foot ulcers account for 26% of all hospitalizations among diabetic patients. Besides, the emerging markets of Asia and Africa report a surge in the wound care needs owing to the inadequately managed diabetes and wound care, thus further amplifying the demand.
Furthermore, the supply chain for collagen dressings primarily relies on the pharmaceutical-grade collagen sourced from bovine, porcine, and marine extracts, with critical API suppliers located in the U.S., Germany, and China, states the U.S. FDA. On the other hand, the regulatory compliance, particularly FDA 21 CFR Part 820 and EU MDR 2017/745, governs production, with sterilization and packaging facilities especially established in India, Mexico, and Eastern Europe to reduce costs. Further, WTO States that manufacturing hubs in Puerto Rico, Ireland, and Singapore are highly benefited from tax incentives, thereby supporting large-scale production, hence a positive outlook for the market.
